Welcome to our dedicated page for Quipt Home Medical news (Ticker: QIPT), a resource for investors and traders seeking the latest updates and insights on Quipt Home Medical stock.
Quipt Home Medical Corp. (QIPT) generates a steady flow of news as a U.S.-based home medical equipment provider focused on end-to-end respiratory care and in-home chronic disease management. Company press releases regularly discuss its role in providing in-home monitoring and disease management services for patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions in the United States healthcare market.
News coverage for QIPT commonly includes financial results and operational updates. For example, Quipt issues quarterly and annual earnings releases that highlight revenue trends, recurring revenue from equipment rentals and respiratory resupplies, Adjusted EBITDA, and operational metrics such as the number of unique patients served and set-ups or deliveries completed. These releases often include management commentary on business performance, revenue stabilization, and the contribution of acquisitions and partnerships.
Another major category of Quipt news involves strategic transactions. The company has announced acquisitions of durable medical equipment providers and a joint venture interest in Hart Medical Equipment, as well as a preferred provider agreement with Ballad Health. These items describe how Quipt works with health systems and hospitals to integrate home medical equipment and respiratory care into hospital discharge processes and post-acute care coordination.
More recently, Quipt’s news has featured corporate and M&A developments, including activist shareholder commentary and, most notably, the December 2025 announcement of a definitive Arrangement Agreement under which a special purpose acquisition vehicle funded by affiliates of Kingswood Capital Management and Forager Capital Management will acquire all outstanding Quipt shares for cash. This transaction, if completed, is expected to result in Quipt becoming a privately held company and its shares being delisted from The Nasdaq Capital Market and the Toronto Stock Exchange.
Investors and observers using this QIPT news page on Stock Titan can review these earnings announcements, acquisition and joint venture updates, health system partnership news, and transaction-related disclosures in one place, helping them understand how Quipt’s home medical equipment and respiratory care strategy is reflected in its public communications.
Quipt Home Medical Corp. (NASDAQ: QIPT) reported a 41% increase in revenue for Q3 2021, totaling $26.2 million, compared to $18.6 million in Q3 2020. Year-to-date, the Company achieved 11% organic growth. Adjusted EBITDA rose 21% to $5.3 million, with a margin of 20.2%. Net income was $6.3 million or $0.19 per share. The Company reported 75% recurring revenue and increased its customer base by 74%. Quipt continues its expansion strategy, integrating three new acquisitions with estimated annual revenues of $5.5 million.
Quipt Home Medical Corp. (NASDAQ: QIPT) recently announced the acquisition of a Missouri-based business, expected to generate $5.5 million in annualized revenues and increase Adjusted EBITDA by $1.1 million post-integration.
The transaction, valued at approximately $2.25 million in cash, adds three new locations and 15,000 active patients, enhancing Quipt's network of 145,000 active patients and 60 locations across the U.S.
Quipt Home Medical Corp. (NASDAQ:QIPT) is set to release its third quarter 2021 financial results on August 23, 2021, after market close. CEO Gregory Crawford and CFO Hardik Mehta will host a conference call on August 24, 2021, at 10:00 a.m. ET. The company specializes in in-home monitoring and disease management services, particularly for respiratory care, and aims to enhance shareholder value by expanding its service offerings. Quipt's strategy focuses on increasing annual revenue per patient by providing multiple services to streamline patient care.
Quipt Home Medical Corp. (NASDAQ:QIPT) will host a webcast presentation on August 11, 2021, at the 41st Annual Canaccord Growth Conference.
The presentation, taking place at 8:30 AM EDT, will be accessible via the investors' section of Quipt's website. The company specializes in home medical equipment and end-to-end respiratory care, aiming to enhance patient services and expand its chronic disease management offerings.
For detailed information, visit Quipt's website.
Quipt Home Medical Corp. has expanded its national footprint by acquiring three entities across California, Missouri, Arkansas, and Mississippi.
These acquisitions are expected to generate approximately $5.5 million in annualized revenues and an Adjusted EBITDA margin of 10% prior to integration.
With the addition of over 10,000 active patients and six locations, Quipt aims to leverage existing infrastructure for enhanced growth and efficiency.
Quipt Home Medical Corp. has successfully exercised common share purchase warrants, generating proceeds of $17.5 million over the past 12 months. The company issued 3,389,825 common shares at a price of CAD$6.40 each, with the vast majority issued since April 2021. Following this issuance, Quipt's total common shares outstanding stands at 33,102,529. CEO Greg Crawford views the warrant exercises as a strong vote of confidence from shareholders, expressing optimism about the company's acquisition plans and its future growth in the durable medical equipment sector.
Quipt Home Medical (NASDAQ:QIPT) will present at the Access to Giving Virtual Investor Conference from July 13-15, 2021. CEO Greg Crawford is set to speak on July 13 at 10:30 a.m. EDT. The conference aims to enhance investor education, featuring over 50 companies and various panels. Quipt will also hold one-on-one meetings for potential investors. Attendance is free, and the presentation will be available via live webcast.
Quipt Home Medical Corp. (NASDAQ:QIPT; TSXV:QIPT) announced a webcasted presentation on June 24, 2021, during the Sidoti Virtual Investor Conference.
The live event will commence at 9:15 AM ET, aimed at sharing the company's growth story and plans to expand its shareholder base following its Nasdaq listing. CEO Greg Crawford expressed optimism about their acquisition pipeline and the potential for strong growth in the second half of the year.
Quipt provides in-home monitoring and chronic disease management services, primarily focusing on respiratory care.
Quipt Home Medical Corp. reported a 36% revenue increase in Q2 2021, totaling $24.2 million compared to $17.9 million in Q2 2020. The company achieved 13% organic growth year-to-date, with recurring revenue exceeding 75% of total revenue. Adjusted EBITDA rose 28% year-over-year to $5.4 million. Noteworthy operational metrics include a 155% increase in respiratory resupply setups. Following a successful NASDAQ listing and recent expansion efforts, including new locations in Daytona Beach and Concord, Quipt is well-positioned for future growth.
Quipt Home Medical Corp. began trading on the Nasdaq Capital Market under the symbol QIPT as of May 27, 2021, while continuing its listing on the TSX Venture Exchange. The company, which focuses on home medical equipment and respiratory care, operates across 51 locations in 11 states, serving over 120,000 active patients. CEO Greg Crawford emphasized that this listing enhances global visibility and liquidity for investors. Additionally, Quipt plans to hold a Q2 earnings conference call on June 1, 2021, at 10:00 a.m. (EST).